Continued favorable results in the treatment of cancer of the prostate gland through the use of stilbestrol therapy are reported in the December issue of the Journal of Urology by Dr. Pierre Jorda Kahle, professor of urology at the L. S. U. school of medicine, Dr. Edward Leroy Burns, assistant professor of pathology a'nd bacteriology at L. S. U., and Dr. John R. Schenken.
The medical paper is a "progress" report on seven cases concerning which detailed findings were given a year previously. In two instances the patients -under treatment had disappeared from view and could not be contacted. Their deaths had not been report-ed at the time records were checked, and they were Negroes of such an advanced a£e as to have made it unlikely that they had left the state.
"At present," the article observes, "we have under treatment with stilbestrol some thirty patients with carcinoma of the prostate gland, none of whom has been submitted to any surgical procedure. .The results parallel those reported in the cases described in this paper and side effects are completely lacking. When the period of observation is sufficiently long these cases will also be reported."
